NIHR-supported trial tests a rapid, low-cost point-of-care test that can diagnose flu, COVID‑19, and RSV in minutes, potentially speeding up winter diagnosis and care across the NHS.
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
The government has confirmed that from the 15th of February travellers entering the UK from a country on the travel ban list will be required to quarantine in a government-approved hotel.
A new study from Umeå University and Karolinska Institutet has found that people with severe mental disorders have a significantly increased risk of dying from COVID-19.
Jade Brooks, an associate solicitor at Blaser Mills Law, responds to The Supreme Court’s ruling on coronavirus-related business interruption insurance claims and discusses what it means for policyholders.
The vaccine roll out gives hope of a return to some form of normality, but current high COVID-19 infection numbers put the success of vaccination programmes at risk. Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences explain why.
A new study by the University of California, Davis has found that a third of Americans are either unlikely or hesitant to get a COVID-19 vaccine when it becomes available.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
Engineers at the University of Bath have published a mathematical model that could help clinicians to safely ventilate two COVID patients on one ventilator.
